{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:25:27Z","timestamp":1773692727685,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K08 DK081830"],"award-info":[{"award-number":["K08 DK081830"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AA020703"],"award-info":[{"award-number":["R01 AA020703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23-DK090303"],"award-info":[{"award-number":["K23-DK090303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCSD In Vivo Cancer and Molecular Imaging Program","award":["P50 CA114745"],"award-info":[{"award-number":["P50 CA114745"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.nucmedbio.2015.11.009","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T12:45:41Z","timestamp":1449060341000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models"],"prefix":"10.1016","volume":"43","author":[{"given":"Bernd","family":"Schnabl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Farshchi-Heydari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Mattrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl K.","family":"Hoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude B.","family":"Sirlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A.","family":"Behling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0020","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cgh.2008.07.013","article-title":"Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials","volume":"6","author":"Loomba","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0030","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0969-8051(03)00113-6","article-title":"Clinical application of TcGSA","volume":"30","author":"Kokudo","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0045","first-page":"350","article-title":"Receptor-binding radiotracers: a class of potential radiopharmaceuticals","volume":"20","author":"Eckelman","year":"1979","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0050","first-page":"1321","article-title":"Phase I clinical study on 99mTc-GSA, a new agent for functional imaging of the liver","volume":"28","author":"Torizuka","year":"1991","journal-title":"Japanese Journal of Nuclear Medicine"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0055","first-page":"1233","article-title":"Technetium-99m NGA functional hepatic imaging: preliminary clinical experience","volume":"26","author":"Stadalnik","year":"1985","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00004424-199301000-00018","article-title":"In vivo functional imaging using receptor-binding radiopharmaceuticals: technetium-99m-galactosyl-neoglycoalbumin as a model","volume":"28","author":"Stadalnik","year":"1993","journal-title":"Invest Radiol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0076-6879(94)47029-4","article-title":"Synthesis and radiolabeling of galactosyl human serum albumin","volume":"247","author":"Kudo","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0070","first-page":"402","article-title":"Methods enzymol","author":"Vera","year":"1994"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0075","first-page":"779","article-title":"Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding","volume":"25","author":"Vera","year":"1984","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1148\/radiology.151.1.6701314","article-title":"[Tc-99m]galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes","volume":"151","author":"Vera","year":"1984","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0085","first-page":"1519","article-title":"Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m-galactosyl-neoglycoalbumin","volume":"30","author":"Vera","year":"1989","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0090","first-page":"1169","article-title":"Measurement of receptor concentration and forward binding rate constant via radiopharmacokinetic model of [99mTc]galactosyl-neoglycoalbumin","volume":"31","author":"Vera","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0095","first-page":"733","article-title":"Receptor measurements via TcGSA kinetic modeling are proportional to functional hepatocellular mass","volume":"42","author":"Miki","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0100","first-page":"160","article-title":"Diagnostic performance of a receptor-binding radiopharmacokinetic model","volume":"37","author":"Vera","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0105","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00268-002-6262-3","article-title":"Predictors of successful hepatic resection - prognostic usefulness of hepatic asialoglycoprotein receptor analysis","volume":"26","author":"Kokudo","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0110","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.27304","article-title":"LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, consensus of the LI-RADS Management Working Group and future directions","volume":"61","author":"Mitchell","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0115","first-page":"268","article-title":"Intrhepatic circulation in liver disease","volume":"15","author":"Huet","year":"1986","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0120","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00259-013-2397-8","article-title":"Development of 68Ga-labeleed DTPA-galactosyl human serum albumin for liver function imaging","author":"Haubner","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0125","first-page":"110","article-title":"Portal-systemic shunts reduce asialoglycoprotein receptor density in rats","volume":"42","author":"Colquhoun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0130","first-page":"663","article-title":"Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity","volume":"18","author":"Kudo","year":"1991","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00004424-198609000-00009","article-title":"ROC methodology in radiologic imaging","volume":"21","author":"Metz","year":"1986","journal-title":"Invest Radiol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0140","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1073\/pnas.1202464109","article-title":"Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist","volume":"109","author":"Iwaisako","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0145","series-title":"1990 Joint Statistical Meetings of the American Statistical Society and the Biometric Society, Anaheim, CA","author":"Metz","year":"1990"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0150","first-page":"814","article-title":"Quantitative assessment of hepatocellular function via in vivo radioreceptor imaging: technetium-99m-galactosyl human serum albumin (Tc-GSA)","volume":"17","author":"Kudo","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2169\/internalmedicine.48.1869","article-title":"Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography","volume":"48","author":"Tobari","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0160","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmri.24755","article-title":"Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults","volume":"41","author":"Murphy","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0165","first-page":"140754","article-title":"Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease","author":"Tang","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0170","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","volume":"60","author":"Loomba","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0175","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0180","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","article-title":"Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease \u2014 MRI accurately quantifies hepatic steatosis in NAFLD","volume":"36","author":"Permutt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jhep.2010.06.022","article-title":"Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis","volume":"54","author":"Gaia","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0205","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/j.ejrad.2011.10.029","article-title":"Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD","volume":"81","author":"Friedrich-Rust","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0210","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.10091662","article-title":"Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography","volume":"256","author":"Yoneda","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiol.11101942","article-title":"Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography","volume":"259","author":"Chen","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0220","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ultrasmedbio.2007.10.009","article-title":"Quantifying hepatic shear modulus in vivo using acoustic radiation force","volume":"34","author":"Palmeri","year":"2008","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0225","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s00535-011-0437-3","article-title":"Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R))","volume":"46","author":"Ebinuma","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0230","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.12.019","article-title":"Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease","volume":"55","author":"Palmeri","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0235","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiol.10100659","article-title":"Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T","volume":"258","author":"Yokoo","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0240","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1245\/s10434-013-2887-8","article-title":"Comparative evaluation of [99mTc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials","volume":"20","author":"Wallace","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nucmedbio.2015.11.009_bb0245","series-title":"Physical chemistry","author":"Moore","year":"1998"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980511530010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980511530010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:24:36Z","timestamp":1537169076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980511530010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S096980511530010X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.11.009","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}